The Potential of Prognostic Biomarkers of Uric Acid Levels in Coronary Heart Disease Among Aged Population: A Scoping Systematic Review of the Latest Cohort Evidence

References

• Bagheri B, Zargari M, Meshkini F, et al. Uric acid and coronary artery disease, two sides of a single coin: a determinant of antioxidant system or a factor in metabolic syndrome. J Clin Diagn Res. 2016;10(2):OC27–31. doi:10.7860/JCDR/2016/16335.7281
   PubMed Web of Science ®Google Scholar
• Duplancic D, Kukoc-Modun L, Modun D, Radic N. Simple and rapid method for the determination of uric acid-independent antioxidant capacity. Molecules. 2011;16(8):7058–7068. doi:10.3390/molecules16087058
   PubMed Web of Science ®Google Scholar
• Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem. 1996;239(1):70–76. doi:10.1006/abio.1996.0292
   PubMed Web of Science ®Google Scholar
• Modun D, Music I, Vukovic J, et al. The increase in human plasma antioxidant capacity after red wine consumption is due to both plasma urate and wine polyphenols. Atherosclerosis. 2008;197(1):250–256. doi:10.1016/j.atherosclerosis.2007.04.002
   PubMed Web of Science ®Google Scholar
• Liang L, Hou X, Bainey KR, et al. The association between hyperuricemia and coronary artery calcification development: a systematic review and meta-analysis. Clin Cardiol. 2019;42(11):1079–1086. doi:10.1002/clc.23266
   PubMed Web of Science ®Google Scholar
• Wijnands JMA, Boonen A, Dagnelie PC, et al. The cross-sectional association between uric acid and atherosclerosis and the role of low-grade inflammation: the codam study. Rheumatol. 2014;53(11):2053–2062. doi:10.1093/rheumatology/keu239
   PubMed Web of Science ®Google Scholar
• Timóteo AT, Lousinha A, Labandeiro J, et al. Serum uric acid: a forgotten prognostic marker in acute coronary syndromes? Eur Hear J Acute Cardiovasc Care. 2013;2(1):44–52. doi:10.1177/2048872612474921
   PubMedGoogle Scholar
• Cao HL, Lv B, Chen X, et al. Relation between uric acid and coronary artery calcification: a community-based cross-sectional survey among Beijing natural population. Zhonghua Liu Xing Bing Xue Za Zhi. 2013;1:548.
   Google Scholar
• Kiss LZ, Bagyura Z, Csobay-Novák C, et al. Serum Uric Acid Is Independently Associated with Coronary Calcification in an Asymptomatic Population. J Cardiovasc Transl Res. 2019;12(3):204–210. doi:10.1007/s12265-018-9843-8
   PubMed Web of Science ®Google Scholar
• Kim H, Kim SH, Choi AR, et al. Asymptomatic hyperuricemia is independently associated with coronary artery calcification in the absence of overt coronary artery disease. Med. 2017. doi:10.1097/MD.0000000000006565
   PubMed Web of Science ®Google Scholar
• Li M, Hu X, Fan Y, et al. Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis. Sci Rep. 2016;6(December 2015):1–11. doi:10.1038/srep19520
   PubMed Web of Science ®Google Scholar
• Zuo T, Liu X, Jiang L, Mao S, Yin X, Guo L. Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies. BMC Cardiovasc Disord. 2016;16(1):1–10. doi:10.1186/s12872-016-0379-z
   PubMed Web of Science ®Google Scholar
• Braga F, Pasqualetti S, Ferraro S, Panteghini M. Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: a systematic review and meta-analysis. Clin Chem Lab Med. 2016;54(1):7–15. doi:10.1515/cclm-2015-0523
   PubMed Web of Science ®Google Scholar
• Bardin T, Richette P. Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC. 2017:1–10. doi:10.1186/s12916-017-0890-9
   Web of Science ®Google Scholar
• Yang Y, Zhou W, Wang YW, Zhou R. Gender-specific association between uric acid level and chronic kidney disease in the elderly health checkup population in China. Ren Fail. 2019;41(1):197–203. doi:10.1080/0886022X.2019.1591994
   PubMed Web of Science ®Google Scholar
• Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32. doi:10.1080/1364557032000119616
   Google Scholar
• Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–473. doi:10.7326/M18-0850
   PubMed Web of Science ®Google Scholar
• Komariah M, Maulana S, Platini H, Pahria T, Scoping A. Review of telenursing’s potential as a nursing care delivery model in lung cancer during the COVID-19 Pandemic. J Multidiscip Healthc. 2021;14:3083–3092. doi:10.2147/JMDH.S337732
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman D, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of Clinical Epidemiology. 2009;62(10):e1–e34.
   PubMedGoogle Scholar
• Baumann S, Huseynov A, Koepp J, et al. Comparison of Serum Uric Acid, Bilirubin, and C-Reactive Protein as Prognostic Biomarkers of In-Hospital MACE between Women and Men with ST-Segment Elevation Myocardial Infarction. Angiology. 2016;67(3):272–280. doi:10.1177/0003319715589246
   PubMed Web of Science ®Google Scholar
• Li Y-H, Lin G-M, Lin C-L, Wang J-H, Chen Y-J, Han C-L. Relation of serum uric acid and body mass index to mortality in high-risk patients with established coronary artery disease: a report from the ET-CHD registry, 1997–2006. J Cardiol. 2013;62(6):354–360. doi:10.1016/j.jjcc.2013.06.002
   PubMed Web of Science ®Google Scholar
• Ndrepepa G, Cassese S, Braun S, et al. A gender-specific analysis of association between hyperuricaemia and cardiovascular events in patients with coronary artery disease. Nutr Metab Cardiovasc Dis. 2013;23(12):1195–1201. doi:10.1016/j.numecd.2013.03.005
   PubMed Web of Science ®Google Scholar
• Ando K, Takahashi H, Watanabe T, et al. Impact of serum uric acid levels on coronary plaque stability evaluated using integrated backscatter intravascular ultrasound in patients with coronary artery disease. J Atheroscler Thromb. 2016;23(8):932–939. doi:10.5551/jat.33951
   PubMed Web of Science ®Google Scholar
• Liu C-W, Liao P-C, Chen K-C, et al. Relationship of serum uric acid and Killip class on mortality after acute ST-segment elevation myocardial infarction and primary percutaneous coronary intervention. Int J Cardiol. 2017;226:26–33. doi:10.1016/j.ijcard.2016.10.025
   PubMed Web of Science ®Google Scholar
• Liu K-L, Lee H-F, Chou S-H, et al. Acute gouty arthritis complicated with acute ST elevation myocardial infarction is independently associated with short- and long-term adverse non-fatal cardiac events. Clin Rheumatol. 2014;33(1):91–98. doi:10.1007/s10067-013-2376-2
   PubMed Web of Science ®Google Scholar
• Lin G-M, Li Y-H, Zheng N-C, et al. Serum uric acid as an independent predictor of mortality in high-risk patients with obstructive coronary artery disease: a prospective observational cohort study from the ET-CHD registry, 1997–2003. J Cardiol. 2013;61(2):122–127. doi:10.1016/j.jjcc.2012.09.004
   PubMed Web of Science ®Google Scholar
• Joo HJ, Jeong HS, Kook H, et al. Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis. BMC Cardiovasc Disord. 2018;18(1). doi:10.1186/s12872-018-0840-2
   PubMed Web of Science ®Google Scholar
• Lopez-Pineda A, Cordero A, Carratala-Munuera C, et al. Hyperuricemia as a prognostic factor after acute coronary syndrome. Atherosclerosis. 2018;269:229–235. doi:10.1016/j.atherosclerosis.2018.01.017
   PubMed Web of Science ®Google Scholar
• Larsen TR, Gerke O, Diederichsen ACP, et al. The association between uric acid levels and different clinical manifestations of coronary artery disease. Coron Artery Dis. 2018;29(3):194–203. doi:10.1097/MCA.0000000000000593
   PubMed Web of Science ®Google Scholar
• Duran M, Ornek E, Murat SN, et al. High levels of serum uric acid impair development of coronary collaterals in patients with acute coronary syndrome. Angiology. 2012;63(6):472–475. doi:10.1177/0003319711422433
   PubMed Web of Science ®Google Scholar
• Yu J, Han J, Mao J, Guo L, Gao W. Association between serum uric acid level and the severity of coronary artery disease in patients with obstructive coronary artery disease. Chin Med J. 2014;127(6):1039–1045.
   PubMed Web of Science ®Google Scholar
• Teng GG, Ang LW, Saag KG, Yu MC, Yuan JM, Koh WP. Mortality due to coronary heart disease and kidney disease among middle-aged and elderly men and women with gout in the Singapore Chinese Health Study. Ann Rheum Dis. 2012;71(6):924–928. doi:10.1136/ard.2011.200523
   PubMed Web of Science ®Google Scholar
• Berezin AE, Kremzer AA. Serum Uric Acid as a Marker of Coronary Calcification in Patients with Asymptomatic Coronary Artery Disease with Preserved Left Ventricular Pump Function. Cardiol Res Pract. 2013;1–7. doi:10.1155/2013/129369
   Google Scholar
• Eisen A, Benderly M, Goldbourt U, Haim M. Is serum uric acid level an independent predictor of heart failure among patients with coronary artery disease? Clin Cardiol. 2013;36(2):110–116. doi:10.1002/clc.22083
   PubMed Web of Science ®Google Scholar
• Ranjith N, Myeni NN, Sartorius B, Mayise C. Association Between Hyperuricemia and Major Adverse Cardiac Events in Patients with Acute Myocardial Infarction. Metab Syndr Relat Disord. 2017;15(1):18–25. doi:10.1089/met.2016.0032
   PubMed Web of Science ®Google Scholar
• Kawabe M, Sato A, Hoshi T, et al. Gender differences in the association between serum uric acid and prognosis in patients with acute coronary syndrome. J Cardiol. 2016;67(2):170–176. doi:10.1016/j.jjcc.2015.05.009
   PubMed Web of Science ®Google Scholar
• Gaubert M, Marlinge M, Alessandrini M, et al. Uric acid levels are associated with endothelial dysfunction and severity of coronary atherosclerosis during a first episode of acute coronary syndrome. Purinergic Signal. 2018;14(2):191–199. doi:10.1007/s11302-018-9604-9
   PubMed Web of Science ®Google Scholar
• Calvo RY, Araneta MRG, Kritz-Silverstein D, Laughlin GA, Barrett-Connor E. Relation of serum uric acid to severity and progression of coronary artery calcium in postmenopausal white and Filipino women (from the Rancho Bernardo study). Am J Cardiol. 2014;113(7):1153–1158. doi:10.1016/j.amjcard.2013.12.022
   PubMed Web of Science ®Google Scholar
• Karabağ Y, Rencuzogullari I, Çağdaş M, et al. Association of serum uric acid levels with SYNTAX score II and long term mortality in the patients with stable angina pectoris who undergo percutaneous coronary interventions due to multivessel and/or unprotected left main disease. Int J Cardiovasc Imaging. 2019;35(1):1–7. doi:10.1007/s10554-018-1446-6
   PubMed Web of Science ®Google Scholar
• Sinan Deveci O, Kabakci G, Okutucu S, et al. The association between serum uric acid level and coronary artery disease. Int J Clin Pract. 2010;64(7):900–907. doi:10.1111/j.1742-1241.2009.02263.x
   PubMed Web of Science ®Google Scholar
• Sauer B, VanderWeele TJ. Use of Directed Acyclic Graphs. Dev a Protoc Obs Comp Eff Res a User’s Guid. 2013;2:177–184.
   Google Scholar
• Lindholm D, Lindbäck J, Armstrong PW, et al. Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease. J Am Coll Cardiol. 2017;70(7):813–826. doi:10.1016/j.jacc.2017.06.030
   PubMed Web of Science ®Google Scholar
• Kaya EB, Yorgun H, Canpolat U, et al. Serum uric acid levels predict the severity and morphology of coronary atherosclerosis detected by multidetector computed tomography. Atherosclerosis. 2010;213(1):178–183. doi:10.1016/j.atherosclerosis.2010.08.077
   PubMed Web of Science ®Google Scholar
• Xia S, Deng SB, Wang Y, et al. Clinical analysis of the risk factors of slow coronary flow. Heart Vessels. 2011;26(5):480–486. doi:10.1007/s00380-010-0081-5
   PubMed Web of Science ®Google Scholar
• Maruhashi T, Hisatome I, Kihara Y, Higashi Y. Hyperuricemia and endothelial function: from molecular background to clinical perspectives. Atherosclerosis. 2018;278(October 2018):226–231. doi:10.1016/j.atherosclerosis.2018.10.007
   PubMed Web of Science ®Google Scholar
• Muiesan ML, Agabiti-Rosei C, Paini A, Salvetti M. Uric acid and cardiovascular disease: an update. Eur Cardiol Rev. 2016;11(1):54–59. doi:10.15420/ecr.2016:4:2
   PubMed Web of Science ®Google Scholar
• Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;16(12):3553–3562. doi:10.1681/ASN.2005050572
   PubMed Web of Science ®Google Scholar
• Larsen KS, Pottegård A, Lindegaard HM, Hallas J. Effect of Allopurinol on Cardiovascular Outcomes in Hyperuricemic Patients Cohort Study A. Am J Med. 2016;129(3):299–306.e2. doi:10.1016/j.amjmed.2015.11.003
   PubMed Web of Science ®Google Scholar
• Ullah W, Khanal S, Khan R, et al. Efficacy of Allopurinol in Cardiovascular Diseases: a Systematic Review and Meta-Analysis. Cardiol Res. 2020;11(4):226–232. doi:10.14740/cr1066
   PubMed Web of Science ®Google Scholar
• Saito Y, Tanaka A, Node K, Kobayashi Y. Uric acid and cardiovascular disease: a clinical review. J Cardiol. 2021;78(1):51–57. doi:10.1016/j.jjcc.2020.12.013
   PubMed Web of Science ®Google Scholar
• Kakutani-Hatayama M, Kadoya M, Okazaki H, et al. Nonpharmacological Management of Gout and Hyperuricemia: hints for Better Lifestyle. Am J Lifestyle Med. 2017;11(4):321–329. doi:10.1177/1559827615601973
   PubMed Web of Science ®Google Scholar
• Vedder D, Walrabenstein W, Heslinga M, et al. Dietary interventions for gout and effect on cardiovascular risk factors: a systematic review. Nutrients. 2019;11(12):1–19. doi:10.3390/nu11122955
   Web of Science ®Google Scholar
• Zhou J, Wang Y, Lian F, et al. Physical exercises and weight loss in obese patients help to improve uric acid. Oncotarget. 2017;8(55):94893–94899. doi:10.18632/oncotarget.22046
   PubMedGoogle Scholar